MassMutual Private Wealth & Trust’s Meridian Bioscience Inc VIVO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28	Closed	-$1K	–	1929
2022 Q4	$1K	Buy	+28	New	+$902	﹤0.01%	1615

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MassMutual Private Wealth & Trust's VIVO Position: Q1 2023 in Review

MassMutual Private Wealth & Trust sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 28 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $1K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

MassMutual Private Wealth & Trust reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 28 Meridian Bioscience Inc shares in Q1 2023, an estimated $1K.
MassMutual Private Wealth & Trust first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
MassMutual Private Wealth & Trust's Meridian Bioscience Inc position peaked at $1K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2023, filed 11 Apr 2023.